Best HealthTech Companies in United Kingdom
The 3879 best HealthTech companies in United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Isomorphic Labs.
Ranking the United Kingdom's most-funded HealthTech companies by disclosed equity and recent momentum, this directory tracks 3,879 firms carrying $14.3B in total disclosed funding. That's not a rounding error. The global HealthTech market sat at roughly $908.5B in 2023 and is forecast to reach $3,140.9B by 2033, a 13.1% CAGR that makes the UK's funding base look like early innings. Four unicorns sit inside this directory, and the funding distribution is steep. Isomorphic Labs alone has pulled $2.7B, which dwarfs every other name on the list. Oviva at $118M and Automata at $107M are the next tier down, and you can feel the gap.
So what's actually driving capital here? Digital health consultation and telehealth platforms are the hot themes right now, with investors like Entrepreneur First and Bethnal Green Ventures writing early checks and Mercia following into later rounds. Data privacy compliance is the structural friction most founders underestimate, and it's real. I'd flag that regulatory complexity tends to compress margins before it compresses valuations, which means the revenue story matters more than the funding headline. The recent seed activity in integrative oncology signals that even niche clinical verticals are attracting institutional attention. Coverage is rising. The companies worth watching are the ones earning, not just raising.
- Big Pharma shuffles investments--and people--around the industry
- Pharma CEOs downplay impact of tariffs amid rising cost concerns
- Challenges in the Secondary Manufacture of Encapsulated High-Potency Drugs
Our analysis of 80 HealthTech companies
$5.5b in tracked funding; 96% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best HealthTech companies in United Kingdom
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Market signals (1y) | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Isomorphic Labs Digital platform focused on revolutionizing drug discovery using AI 60Funding top 12%AI top 20%Innovation top 30%Patents top 33% All 11 signals ▾Fundingtop 12% AItop 20% Innovationtop 30% Patentstop 33% Moattop 39% Talentbottom 49% Growthbottom 47% Techbottom 46% Globalbottom 37% Marketbottom 36% Newsbottom 25% Funding: Raised $2.7B across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Classified as an AI company rank vs industry peers · Fliar Intelligence Index 60/100 | $2.7B | 1 mo ago | Series B | — | Demis Hassabis Founder & CEO | — | 19 patents AI-driven drug discovery: protein‑ligand modeling, molecule property prediction, synthesis feasibility. | — |
| 2 | Cera 🦄 Provider of a digital-first home healthcare provider that offers personalized care solutions to patients 84Fin. health top 21%Funding top 22%Talent top 23%Innovation top 25% All 11 signals ▾Fin. healthtop 21% Fundingtop 22% Talenttop 23% Innovationtop 25% Moattop 26% Techtop 28% Markettop 33% Newstop 33% Producttop 34% Growthtop 47% Globalbottom 39% Fin. health: Revenue ~$280M · Revenue +27% YoY Funding: Raised $421M across 9 rounds · 9 rounds over 10 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 84/100 | $421M | 17 mo ago | Series C | 60 | Martin Ocenas Co-Founder & Director of Engineering | 16 signals ▲100% Announcements · New product · Capital raise | — | — |
| 3 | Huma Developer of digital health software for clinical workflows and research 42Funding top 24%Product top 24%Moat top 31%Customers top 33% All 11 signals ▾Fundingtop 24% Producttop 24% Moattop 31% Customerstop 33% Talenttop 38% Techtop 41% Markettop 50% Growthbottom 42% Globalbottom 39% Newsbottom 21% Fin. healthbottom 21% Funding: Raised $317M across 13 rounds · 13 rounds over 13 yrs (1.0/yr) Product: 12 published apps (91.8k installs) · Company stage: Series D rank vs industry peers · Fliar Intelligence Index 42/100 | $317M | 13 mo ago | Series D | 287 | Rich Khatib Co-Founder | — | — | 4 job openings · 1 partnership |
| 4 | Flo 🦄 Provider of AI based mobile app that tracks and predicts menstrual cycles 96Customers top 9%Fin. health top 11%Patents top 16%Market top 17% All 14 signals ▾Customerstop 9% Fin. healthtop 11% Patentstop 16% Markettop 17% Talenttop 22% Innovationtop 23% Fundingtop 23% Moattop 25% Techtop 27% Producttop 32% AItop 35% Globaltop 40% Growthtop 41% Newsbottom 18% Customers: Play-Store rating 4.70★ across 4,924,913 ratings (1 apps) · Review volume +11% in 6 mo Fin. health: Revenue ~$139M · Revenue +211% YoY rank vs industry peers · Fliar Intelligence Index 96/100 | $269M | 22 mo ago | Series C | 425 | Max Scrobov Co-Founder & CPO | — | 56 patents Patents concentrated in chemistry & materials | — |
| 5 | Oviva Provider of an online nutritional consultation platform for patients 87Customers top 13%Fin. health top 18%Funding top 22%Tech top 23% All 11 signals ▾Customerstop 13% Fin. healthtop 18% Fundingtop 22% Techtop 23% Markettop 30% Producttop 30% Moattop 31% Growthtop 32% Newstop 32% Talentbottom 49% Globalbottom 42% Customers: Play-Store rating 4.60★ across 28,251 ratings (2 apps) · Review volume +17% in 6 mo Fin. health: Revenue ~$54.7M (FY2025) · Net margin 23.4% rank vs industry peers · Fliar Intelligence Index 87/100 | $118M | 4 mo ago | Series D | 245 | Kai Eberhardt Co-Founder & CEO | 3 signals ▲200% Funding | — | — |
| 6 | Automata Developer of modular lab automation platforms for biological research workflows 64Funding top 25%Product top 25%Tech top 27%Moat top 31% All 11 signals ▾Fundingtop 25% Producttop 25% Techtop 27% Moattop 31% Innovationtop 32% Fin. healthtop 33% Newstop 43% Growthtop 48% Talentbottom 49% Marketbottom 44% Globalbottom 39% Funding: Raised $107M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) Product: 7 distinct product lines · Company stage: Series C rank vs industry peers · Fliar Intelligence Index 64/100 | $107M | 4 mo ago | Series C | 40 | Mostafa ElSayed Co-Founder & CEO | — | — | 1 partnership |
| 7 | Numan Provider of an online doctor consultation platform for men's health 74Funding top 24%Fin. health top 24%Moat top 24%News top 25% All 10 signals ▾Fundingtop 24% Fin. healthtop 24% Moattop 24% Newstop 25% Techtop 29% Growthtop 35% Markettop 44% Producttop 46% Talentbottom 49% Globalbottom 39% Funding: Raised $82.6M across 7 rounds · 7 rounds over 8 yrs (0.9/yr) Fin. health: Revenue ~$28.8M rank vs industry peers · Fliar Intelligence Index 74/100 | $83M | 11 mo ago | Series B | 17 | Sokratis Papafloratos Founder & CEO | 4 signals Funding · Capital raise | — | — |
| 8 | Manual Manufacturer of men's care products 83Fin. health top 13%Growth top 21%Tech top 21%Funding top 25% All 9 signals ▾Fin. healthtop 13% Growthtop 21% Techtop 21% Fundingtop 25% Moattop 35% Markettop 45% Talentbottom 49% Globalbottom 39% Newsbottom 21% Fin. health: Revenue ~$68.1M · Revenue +144% YoY Growth: Revenue +144% YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 83/100 | $75M | 9 mo ago | Series B | 17 | George Pallis Co-Founder | — | — | — |
| 9 | Unmind Cloud-based mental well-being program for employers 78Tech top 14%News top 18%Funding top 26%Moat top 31% All 11 signals ▾Techtop 14% Newstop 18% Fundingtop 26% Moattop 31% Fin. healthtop 35% Growthtop 37% Markettop 38% Talenttop 38% Producttop 46% Customersbottom 48% Globalbottom 45% Tech: 49 technologies across 6/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 News: 5 BI events in 12 mo (of 18 tracked, 5 types) · 4 high-value events (IPO/M&A/funding/contracts) in 12 mo rank vs industry peers · Fliar Intelligence Index 78/100 | $74M | 9 mo ago | Series C | 194 | Steve Peralta Co-Founder | 5 signals Funding · Capital raise | — | — |
| 10 | Relation AI-based drug development tools for researchers 55Funding top 25%Talent top 28%AI top 30%Growth top 35% All 8 signals ▾Fundingtop 25% Talenttop 28% AItop 30% Growthtop 35% Moattop 36% Techbottom 43% Globalbottom 37% Marketbottom 27% Funding: Raised $65.3M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $65M | 6 mo ago | Seed | 12 | Jake Taylor-King Co-Founder & Chief Innovation Officer | — | — | 1 partnership · 1 award |
| 11 | Ultromics Developer of artificial intelligence software for analyzing cardiac ultrasound images 67Funding top 27%News top 28%AI top 30%Moat top 31% All 12 signals ▾Fundingtop 27% Newstop 28% AItop 30% Moattop 31% Growthtop 33% Talenttop 38% Innovationtop 39% Patentstop 40% Techtop 50% Marketbottom 49% Fin. healthbottom 46% Globalbottom 42% Funding: Raised $60.6M across 6 rounds · 6 rounds over 9 yrs (0.7/yr) News: 4 BI events in 12 mo (of 7 tracked, 2 types) · Top themes: Funding, Capital raise rank vs industry peers · Fliar Intelligence Index 67/100 | $61M | 5 mo ago | Series C | 49 49 → 85 (+73%) · sector median +10% | Ross Upton Co-Founder & CEO | 4 signals Funding · Capital raise | 9 patents AI-driven analysis of cardiac imaging data for diagnostic parameter extraction | 1 launch |
| 12 | Latentlabs Developer of generative AI models for programmable biology 60Funding top 25%AI top 30%Growth top 35%Moat top 40% All 8 signals ▾Fundingtop 25% AItop 30% Growthtop 35% Moattop 40% Talentbottom 49% Globalbottom 48% Techbottom 43% Marketbottom 40% Funding: Raised $50.0M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) AI: Classified as an AI company · Product described with: generative ai rank vs industry peers · Fliar Intelligence Index 60/100 | $50M | 16 mo ago | Series A | — | Simon Kohl Founder & CEO | — | — | — |
| 13 | Chemify Developer of a platform for digitizing chemistry and chemical discovery 64Growth top 20%Funding top 26%AI top 30%Tech top 40% All 11 signals ▾Growthtop 20% Fundingtop 26% AItop 30% Techtop 40% Talentbottom 49% Marketbottom 44% Globalbottom 42% Moatbottom 42% Patentsbottom 40% Innovationbottom 39% Newsbottom 17% Growth: Web rank 50,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo Funding: Raised $43.0M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $43M | 4 mo ago | Series B | 40 | Lee Cronin Founder & CEO | — | 2 patents Modular catalytic reactors and networked chemical processing platforms for scalable synthesis | — |
| 14 | Laverock Therapeutics Developer of next generation of programmable cell therapies 24Funding top 29%Moat top 42%Talent bottom 49%Global bottom 45% All 6 signals ▾Fundingtop 29% Moattop 42% Talentbottom 49% Globalbottom 45% Techbottom 43% Marketbottom 27% Funding: Raised $39.3M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) Moat: Editorial + unicorn rating 4/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 24/100 | $39M | 11 mo ago | Seed | 6 | David Venables CEO | — | — | — |
| 15 | SmpliCare Provider of a questionnaire-based health monitoring tool for elderly patients 21News top 29%Talent top 38%Funding top 43%Product bottom 40% All 6 signals ▾Newstop 29% Talenttop 38% Fundingtop 43% Productbottom 40% Globalbottom 30% Marketbottom 29% News: 3 BI events in 12 mo (of 3 tracked, 1 types) · Top themes: Funding Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 21/100 | $35M | 10 mo ago | Seed | 1 | Alexandra Melling Co-Founder & COO | 3 signals Funding | — | — |
| 16 | Brainomix Developer of automated medical imaging software for stroke and lung 64AI top 18%Funding top 28%Patents top 31%Fin. health top 35% All 13 signals ▾AItop 18% Fundingtop 28% Patentstop 31% Fin. healthtop 35% Producttop 40% Innovationtop 42% Growthtop 46% Moattop 46% Techtop 47% Talentbottom 49% Marketbottom 45% Globalbottom 45% Newsbottom 37% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Funding: Raised $34.8M across 8 rounds · 8 rounds over 12 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 64/100 | $35M | 7 mo ago | Series C | 29 | Michalis Papadakis Co-Founder & CEO | — | 19 patents AI-driven quantitative analysis of medical imaging for lung disease and lesion assessment | — |
| 17 | TERN Provider of international healthcare recruitment and relocation services 60Funding top 26%Tech top 28%Growth top 35%Talent top 38% All 7 signals ▾Fundingtop 26% Techtop 28% Growthtop 35% Talenttop 38% Globalbottom 42% Moatbottom 38% Marketbottom 36% Funding: Raised $32.8M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Tech: 41 technologies across 5/8 capability areas · Cloud: Amazon Ses, Amazon Web Services rank vs industry peers · Fliar Intelligence Index 60/100 | $33M | 9 mo ago | Series A | — | Krishna Ramkumar Co-Founder & COO | — | — | — |
| 18 | Lupa Pets Platform offering an AI-powered veterinary operating system 64Talent top 28%Growth top 35%Tech top 36%Funding top 39% All 8 signals ▾Talenttop 28% Growthtop 35% Techtop 36% Fundingtop 39% AItop 45% Producttop 47% Globalbottom 48% Marketbottom 37% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 64/100 | $24M | 8 mo ago | Series A | — | Raul Martin Co-Founder & CTO | — | — | 1 partnership · 1 award |
| 19 | Nymbl Science Provider of a wearable device and app for balance diagnosis and therapeutics 50Customers top 23%Talent top 28%Funding top 31%Growth top 35% All 10 signals ▾Customerstop 23% Talenttop 28% Fundingtop 31% Growthtop 35% Moattop 35% Producttop 46% Techbottom 49% Globalbottom 37% Marketbottom 30% Newsbottom 22% Customers: Play-Store rating 4.64★ across 1,544 ratings (1 apps) · Review volume +16% in 6 mo Talent: 4 named leaders on record · 4 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $24M | 9 mo ago | Series B | 22 22 → 18 (-18%) · sector median +10% | Jean-Pierre Farcy Co-Founder | — | — | — |
| 20 | Cirdan Imaging Laboratory Information System for clinical laboratories 53Product top 30%Growth top 31%Moat top 37%Talent top 38% All 12 signals ▾Producttop 30% Growthtop 31% Moattop 37% Talenttop 38% Fundingtop 39% Fin. healthtop 45% Techbottom 47% Marketbottom 46% Globalbottom 45% Innovationbottom 44% Patentsbottom 33% Newsbottom 20% Product: 4 distinct product lines · Company stage: Series B Growth: Revenue +39% YoY · Web rank 50,000,000 → 10,000,000 YoY rank vs industry peers · Fliar Intelligence Index 53/100 | $24M | 2 mo ago | Series B | 84 | Cahal Cormican Co-Founder | — | 6 patents Patents concentrated in health & consumer products | — |
| 21 | Eleven AI-based RNA drug development platform for researchers 55Growth top 28%Talent top 28%Funding top 31%AI top 45% All 8 signals ▾Growthtop 28% Talenttop 28% Fundingtop 31% AItop 45% Newsbottom 48% Techbottom 44% Globalbottom 37% Marketbottom 25% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 55/100 | $22M | 14 mo ago | Seed | 12 12 → 28 (+133%) · sector median +10% | Shaul Ilan Co-Founder | — | — | 1 launch |
| 22 | Techspert Leading expert network for healthcare and life sciences 60Funding top 29%Tech top 30%Growth top 32%Moat top 39% All 7 signals ▾Fundingtop 29% Techtop 30% Growthtop 32% Moattop 39% Talentbottom 49% Globalbottom 46% Marketbottom 42% Funding: Raised $18.1M across 4 rounds · 4 rounds over 8 yrs (0.5/yr) Tech: 43 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 rank vs industry peers · Fliar Intelligence Index 60/100 | $18M | 3 mo ago | Acquired | 53 53 → 71 (+34%) · sector median +10% | David Holden Co-Founder & CEO | — | — | — |
| 23 | Jaaq Provider of a platform offering clinically governed mental health support 35Talent top 28%Funding top 39%Tech top 49%Global bottom 33% All 5 signals ▾Talenttop 28% Fundingtop 39% Techtop 49% Globalbottom 33% Marketbottom 31% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $17.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $17M | 2 mo ago | Series A | — | Danny Gray Co-Founder | — | — | 4 launchs |
| 24 | GripAble Provider of cloud-based rehabilitation device with a companion app for the patients 53Growth top 21%Funding top 32%AI top 45%Talent bottom 49% All 8 signals ▾Growthtop 21% Fundingtop 32% AItop 45% Talentbottom 49% Productbottom 48% Techbottom 45% Globalbottom 37% Marketbottom 27% Growth: Headcount 11 → 27 (+145%) across vintages · Fresh capital in last 24 mo Funding: Raised $16.5M across 6 rounds · 6 rounds over 9 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 53/100 | $17M | 3 mo ago | Series A | 27 27 → 17 (-37%) · sector median +10% | Mike Mace CTO - Cofounder | — | — | — |
| 25 | Cumulus Neuro AI and cloud-based brain physiology analysis tool for clinical trials 62Growth top 20%Funding top 30%News top 33%Moat top 39% All 7 signals ▾Growthtop 20% Fundingtop 30% Newstop 33% Moattop 39% Talentbottom 49% Marketbottom 47% Globalbottom 39% Growth: Headcount 21 → 41 (+95%) across vintages · Fresh capital in last 24 mo Funding: Raised $15.2M across 7 rounds · 7 rounds over 9 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 62/100 | $15M | 11 mo ago | Series A | 41 41 → 35 (-15%) · sector median +10% | Brian Murphy Co-Founder & Chief Scientific Officer | — | — | — |
| 26 | Oxford Medical Simulation Developer of VR-based medical training systems for patient care 50Funding top 34%Growth top 35%Tech top 37%Talent top 38% All 7 signals ▾Fundingtop 34% Growthtop 35% Techtop 37% Talenttop 38% Moattop 48% Globalbottom 37% Marketbottom 32% Funding: Raised $15.0M across 3 rounds · 3 rounds over 8 yrs (0.4/yr) Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 50/100 | $15M | 3 mo ago | Series A | 19 | Michael Wallace Co-Founder | — | — | — |
| 27 | Electric Twin AI-powered digital twin technology for research and clinical applications in the life sciences industry 60Growth top 15%News top 22%Funding top 33%Talent top 38% All 8 signals ▾Growthtop 15% Newstop 22% Fundingtop 33% Talenttop 38% AItop 45% Techtop 46% Globalbottom 32% Marketbottom 25% Growth: Fresh capital in last 24 mo News: 6 BI events in 12 mo (of 6 tracked, 1 types) · 6 high-value events (IPO/M&A/funding/contracts) in 12 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $14M | 9 mo ago | Series A | — | Alex Cooper Co-Founder & CEO | 6 signals Funding | — | 2 awards |
| 28 | IgniteData Provider of solutions for transforming patient data for clinical trials through archer technology 22News top 28%Funding top 39%Moat top 39%Talent top 41% All 6 signals ▾Newstop 28% Fundingtop 39% Moattop 39% Talenttop 41% Globalbottom 37% Marketbottom 28% News: 4 BI events in 12 mo (of 4 tracked, 2 types) · Top themes: Funding, Leadership Funding: Raised $12.7M across 6 rounds · 6 rounds over 9 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 22/100 | $13M | 7 mo ago | Series A | 11 | Dan Hydes Founder | 4 signals Leadership · Funding | — | — |
| 29 | Oxford Drug Design Provider of computer-aided design of antibiotics for MDR infections 32Talent top 28%Funding top 30%Moat top 32%Patents top 38% All 9 signals ▾Talenttop 28% Fundingtop 30% Moattop 32% Patentstop 38% Innovationtop 40% Producttop 41% Globalbottom 40% Marketbottom 26% Techbottom 23% Talent: Analyst team rating 4/5 · 3 named leaders on record Funding: Raised $12.4M across 7 rounds · 7 rounds over 9 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 32/100 | $12M | 4 mo ago | Series A | 9 | Graham Richards Founder & Chairman | — | 46 patents Antibacterial aminoacyl‑tRNA synthetase inhibitors based on sulfonamide/aryl‑sulfinyl scaffolds | — |
| 30 | Flexzo Flexzo AI | AI-Powered Healthcare Staffing Platform 72Funding top 32%Tech top 33%Growth top 35%AI top 45% All 7 signals ▾Fundingtop 32% Techtop 33% Growthtop 35% AItop 45% Talentbottom 49% Productbottom 48% Globalbottom 33% Funding: Raised $12.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Tech: 36 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 rank vs industry peers · Fliar Intelligence Index 72/100 | $12M | 3 mo ago | Series A | — | Jack Henderson Founder & CEO | — | — | 1 award |
| 31 | Scripta Therapeutics Developer of therapeutics modulating transcription factor activity for disease treatment 27Funding top 36%Talent top 38%Tech bottom 49%Global bottom 45% All 5 signals ▾Fundingtop 36% Talenttop 38% Techbottom 49% Globalbottom 45% Marketbottom 25% Funding: Raised $11.9M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 27/100 | $12M | 7 mo ago | Seed | — | Jerry Huang Co-Founder & VP Machine Learning | — | — | — |
| 32 | GoodShape Cloud-based employee wellbeing software provider 64Funding top 35%Tech top 40%Fin. health top 40%Market top 42% All 7 signals ▾Fundingtop 35% Techtop 40% Fin. healthtop 40% Markettop 42% Producttop 47% Growthtop 49% Globalbottom 29% Funding: Raised $10.7M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Tech: 36 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare rank vs industry peers · Fliar Intelligence Index 64/100 | $11M | 3 mo ago | Funding Raised | 143 143 → 91 (-36%) · sector median +10% | — | — | — | — |
| 33 | Antiverse Developer of computational platform for de novo design of antibody therapeutics 48AI top 30%Tech top 32%Talent top 34%Funding top 39% All 8 signals ▾AItop 30% Techtop 32% Talenttop 34% Fundingtop 39% Moattop 48% Newsbottom 41% Globalbottom 39% Marketbottom 22% AI: Classified as an AI company · Product described with: machine learning Tech: 35 technologies across 5/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 48/100 | $10M | 3 mo ago | Series A | 7 | Murat Tunaboylu Co-Founder & CEO | — | — | — |
| 34 | Patients Know Best Provider of personal health records management software for healthcare organizations 69Tech top 27%Funding top 36%Product top 36%Talent top 38% All 9 signals ▾Techtop 27% Fundingtop 36% Producttop 36% Talenttop 38% Innovationtop 39% Moattop 39% Growthtop 40% Markettop 43% Globalbottom 39% Tech: 55 technologies across 6/8 capability areas · Cloud: Amazon S3, Amazon Web Services Funding: Raised $8.1M across 10 rounds · 10 rounds over 17 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 69/100 | $8M | 9 mo ago | Series A | 59 59 → 97 (+64%) · sector median +10% | Ian Bastow Co-Founder & CFO | — | — | — |
| 35 | Hypervision Surgical AI-based tissue analysis software for surgical precision 27AI top 28%Funding top 35%Moat top 41%Patents top 47% All 9 signals ▾AItop 28% Fundingtop 35% Moattop 41% Patentstop 47% Talentbottom 49% Innovationbottom 48% Globalbottom 39% Techbottom 30% Marketbottom 20% AI: Holds AI/ML patents (G06N-family CPC) · Product described with: ai-based Funding: Raised $8.1M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 27/100 | $8M | 1 mo ago | Series A | 6 | Tom Vercauteren Co-Founder and Chief Scientific Officer (CSO) | — | 5 patents Hyperspectral imaging sensor calibration and joint demosaicking for spectral signature extraction | — |
| 36 | Cyted Leader in non-endoscopic diagnostics for digestive health, enabling early disease detection and access to… 53Talent top 28%Funding top 33%Patents top 33%Growth top 35% All 9 signals ▾Talenttop 28% Fundingtop 33% Patentstop 33% Growthtop 35% Innovationtop 37% Moattop 46% Techbottom 45% Globalbottom 40% Marketbottom 32% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $6.6M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 53/100 | $7M | 9 mo ago | Series B | — | Maria Odonovan Co-Founder & CMO | — | 16 patents Minimally invasive esophageal cell‑sampling devices for Barrett's cancer detection | — |
| 37 | Entourage Provider of proteomic blood tests detecting early signs of potential diseases 40AI top 45%Funding bottom 49%Talent bottom 49%Tech bottom 44% All 5 signals ▾AItop 45% Fundingbottom 49% Talentbottom 49% Techbottom 44% Globalbottom 34% AI: Product described with: machine learning Funding: Raised $5.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $5M | 3 mo ago | Seed | — | Patrick Gunning Founder & CEO | — | — | — |
| 38 | TernaryTx Developer of computational platform for molecular glue discovery and design 24Talent top 38%Funding top 42%AI top 45%Global bottom 48% All 6 signals ▾Talenttop 38% Fundingtop 42% AItop 45% Globalbottom 48% Marketbottom 25% Techbottom 22% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $4.8M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $5M | 3 mo ago | Seed | — | Chris Tame Co-Founder & CEO | — | — | 1 internship |
| 39 | GlycanAge Digital healthcare assessment and management tool for patients and providers 45Growth top 35%Talent top 38%Tech top 42%Funding top 43% All 10 signals ▾Growthtop 35% Talenttop 38% Techtop 42% Fundingtop 43% Patentstop 44% Moattop 45% Innovationbottom 48% Globalbottom 42% Newsbottom 33% Marketbottom 32% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 45/100 | $4M | 6 mo ago | Series A | 22 | Gordan Lauc Co-Founder & CSO | — | 5 patents Glycan-based diagnostic assays for menopause status and estradiol monitoring | 1 partnership |
| 40 | Neupulse Developer of a wearable device for reducing tics associated with Tourette Syndrome 62Growth top 28%Talent top 28%Funding top 46%Tech bottom 49% All 5 signals ▾Growthtop 28% Talenttop 28% Fundingtop 46% Techbottom 49% Globalbottom 33% Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 62/100 | $4M | 4 mo ago | Series A | — | Stephen Jackson Co-Founder & Chief Scientific Officer | — | — | — |
| 41 | Entelo Bio Developer of single-cell isoform sequencing platform for disease research 42Talent top 38%Funding top 47%Global bottom 48% All 3 signals ▾Talenttop 38% Fundingtop 47% Globalbottom 48% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $4.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 42/100 | $4M | 1 mo ago | Series A | — | Adam Cribbs Co-Founder & CTO | — | — | 1 launch · 1 partnership · 1 award |
| 42 | Roxfit Provider of a workout tracking app with intra workout guidance and post workout analysis 48Customers top 25%Growth top 28%Talent top 28%Funding top 50% All 8 signals ▾Customerstop 25% Growthtop 28% Talenttop 28% Fundingtop 50% Productbottom 40% Techbottom 37% Globalbottom 36% Marketbottom 35% Customers: Play-Store rating 4.74★ across 670 ratings (1 apps) Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 48/100 | $4M | 3 mo ago | Seed | — | Tom Allott Co-Founder | — | — | 1 launch |
| 43 | Coding Bio AI-assisted platform for cell therapy development 19AI top 45%Talent top 45%Funding top 49%Global bottom 36% All 5 signals ▾AItop 45% Talenttop 45% Fundingtop 49% Globalbottom 36% Marketbottom 19% AI: Product described with: machine learning Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 19/100 | $3M | 5 mo ago | Seed | 5 | Yulia Lampi Co-Founder | — | — | — |
| 44 | Eolas Medical Provider of an app for communication, education, clinical protocols 42Tech top 33%Growth top 35%Funding top 39%Customers top 41% All 8 signals ▾Techtop 33% Growthtop 35% Fundingtop 39% Customerstop 41% Talentbottom 49% Productbottom 48% Globalbottom 37% Marketbottom 24% Tech: 34 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 42/100 | $3M | 4 mo ago | Series A | 5 | Declan Kelly Founder & CEO | — | — | — |
| 45 | SpaceBands Developer of a wristband for social distancing 24Growth top 35%Talent top 38%Funding top 39%Moat top 45% All 11 signals ▾Growthtop 35% Talenttop 38% Fundingtop 39% Moattop 45% Techtop 50% Patentsbottom 43% Globalbottom 40% Productbottom 40% Innovationbottom 30% Newsbottom 22% Marketbottom 12% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 24/100 | $3M | 5 mo ago | Seed | 3 | Ronan Finnegan Co-Founder | — | 2 patents Wearable IoT networking and hub communication protocols for personal devices | — |
| 46 | Emerald Provider of biannual biomarker testing, GP review, and health insights 37Talent top 28%Growth top 35%Tech top 50%Funding bottom 48% All 6 signals ▾Talenttop 28% Growthtop 35% Techtop 50% Fundingbottom 48% Globalbottom 45% Marketbottom 21% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 37/100 | $2M | 4 mo ago | Seed | — | Anton Shchipanov Co-Founder & CTO | — | — | 2 partnerships |
| 47 | Auryx AI-powered health monitoring solutions through wearable earbuds 62AI top 35%Talent top 38%Funding top 42%Global top 45% All 5 signals ▾AItop 35% Talenttop 38% Fundingtop 42% Globaltop 45% Techbottom 42% AI: Product described with: ai-powered, machine learning Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 62/100 | $2M | 1 mo ago | Seed | — | Cecilia Mascolo Co-Founder & CSO | — | — | 1 award |
| 48 | Shido Provider of multiple fitness services 5Funding top 46%Product bottom 40%Global bottom 25%Market bottom 11% All 4 signals ▾Fundingtop 46% Productbottom 40% Globalbottom 25% Marketbottom 11% Funding: Raised $2.0M across 14 rounds · 14 rounds over 5 yrs (2.8/yr) Product: 1 published app (510 installs) · Company stage: Seed rank vs industry peers · Fliar Intelligence Index 5/100 | $2M | 3 mo ago | Seed | 5 | — | — | — | — |
| 49 | Envoke Provider of an engagement platform for virtual instruments 35Growth top 35%Tech top 44%Funding top 50%Talent bottom 49% All 7 signals ▾Growthtop 35% Techtop 44% Fundingtop 50% Talentbottom 49% Productbottom 45% Globalbottom 37% Marketbottom 25% Growth: Fresh capital in last 24 mo Tech: 30 technologies across 4/8 capability areas · Cloud: Cloudflare rank vs industry peers · Fliar Intelligence Index 35/100 | $1M | 1 mo ago | Seed | — | Stuart Warrington Founder & CEO | — | — | — |
| 50 | Metacarpal Developer of robotic upper-limb prosthetics 16Funding top 42%Moat top 45%Patents top 46%Innovation top 49% All 8 signals ▾Fundingtop 42% Moattop 45% Patentstop 46% Innovationtop 49% Talentbottom 49% Globalbottom 40% Techbottom 34% Marketbottom 15% Funding: Raised $1.1M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Moat: Editorial + unicorn rating 4/10 · IP moat: 4 patents rank vs industry peers · Fliar Intelligence Index 16/100 | $1M | 1 mo ago | Series A | 2 | Fergal Mackie Co-Founder & CEO | — | 4 patents Advanced prosthetic hand and wrist devices for biomechanical rehabilitation | 1 award |
Top 12 HealthTech companies in United Kingdom
#1
Series B · London, England · founded 2021$2.7Braised▾
Digital platform focused on revolutionizing drug discovery using AI. The company's computational tools analyze complex biological phenomena to assist in the design of molecules. The technology predicts how potential therapeutic compounds perform to facilitate the development of treatments for various diseases.
- May 2026Series B$2.1B
- Mar 2025Series A$600M
#2
Series C · London, England · founded 2015 · 40 employees$106.5Mraised▾
Developer of modular lab automation platforms for biological research workflows. This system integrates hardware and software to orchestrate laboratory processes, including sample handling and instrument management. The platform utilizes node-based design tools and software development kits to enable workflow configuration and simulation. It supports connectivity with external data systems and analytical models to facilitate automated execution of experimental protocols. The hardware components are configurable to accommodate various instruments and laboratory layouts, allowing for the management of multiple concurrent tasks.
- Jan 2026Series C$45M
- Oct 2023Series B$40M
- Feb 2022Series B$50M
- Mar 2019Series A$7.4M
#3
Series D · London, England · founded 2014 · 245 employees$118.2Mraised▾
Provider of an online nutritional consultation platform for patients. It offers personalised dietary advice combined with unique digital tools. The dietitian offers personalized guidance based on their needs and answers user's questions in regard to dietary management solutions. They also help users to track their daily activities for better health outcomes. The app gives daily motivation and tips to users to reach their goals.
- Jan 2026Series D—
- Sep 2021Series C$80.3M
- Jan 2020Series B$21M
- Nov 2017Series A$12M
#4
Series B · Lisburn, Northern Ireland · founded 2010 · 84 employees$23.6Mraised▾
Cirdan Imaging designs manufactures and supplies medical imaging & informatics technology for the medical diagnosis and treatment of cancer. The company offers VividPath, a PACS image acquisition and viewer workstation to acquire, view, annotate, report, and store images in a database. Also provides gross specimen macro imaging systems for pathology laboratories; digital microscope cameras to support live onscreen review and image capture of slides; and medical imaging software solutions. The company has additional offices in Canada and Australia and offers products through a network of distributors in Europe, the Middle East, and Africa.
- Apr 2026Series B$4M
- Apr 2026Venture Debt$5.4M
- Oct 2024Series B$9.8M
- Oct 2023Series A$2.8M
#5
Series C · Oxford, England · founded 2017 · 49 employees$60.6Mraised▾
Developer of artificial intelligence software for analyzing cardiac ultrasound images. This technology processes echocardiogram video clips to identify patterns associated with specific heart conditions. The software integrates with existing medical imaging systems to provide automated reports for clinical review. These tools assist in the detection of heart failure and other cardiovascular abnormalities by identifying findings within routine diagnostic scans. The system functions through cloud-based infrastructure to deliver results directly into clinical workflows.
- Dec 2025Series C—
- Jul 2025Series C$55M
- Aug 2021Series B$33M
- Sep 2020Series A$272K
#6
Series B · Glasgow, Scotland · founded 2020 · 40 employees$43Mraised▾
Developer of a platform for digitizing chemistry and chemical discovery. The platform combines chemistry, robotics, computation, machine learning, and a programming language to automate molecule creation. It aims to accelerate molecular discovery and bridge the gap between design and synthesis. The company focuses on developing novel compounds and materials.
- Feb 2026Series B—
- Dec 2025Grant (prize money)$1.6M
- Oct 2025Series B$50M
- Oct 2024Grant (prize money)—
#7
Seed · London, England · founded 2019 · 12 employees$65.3Mraised▾
AI-based drug development tools for researchers. The company has developed software for target and drug discovery. The platform leverages human genetics, single-cell omics, and perturbational data for genetic disease management.
- Nov 2025Seed$36.2M
- Nov 2024Seed$15M
- Jan 2024Seed$40.3M
- May 2022Seed$16M
#8
Series A · London, England · founded 2016 · 27 employees$16.5Mraised▾
Provider of cloud-based rehabilitation device with a companion app for the patients recovering from medical procedures or hospitalization, particularly those affected by stroke. The company has developed a Bluetooth-enabled personal rehabilitation device with a companion app. The app has developed a series of games in which users squeeze the device and loosen their grip to play. It measures grip strength and hand motion to assess and track the patient's cognitive and physical movements over time through a machine learning algorithm.
- Mar 2026Series A$2.7M
- Apr 2022Series A$11M
- Mar 2021Seed$2.2M
- Feb 2019Seed$142.3K
#9
Series D · London, England · founded 2011 · 287 employees$316.7Mraised▾
Developer of digital health software for clinical workflows and research. This platform provides tools for building regulated applications that unify operational and patient data. It enables the creation of digital triage systems, remote monitoring programs, and automated clinical documentation tools. The infrastructure supports the integration of disparate health systems into a federated network to facilitate data-driven decision-making. These tools assist in managing patient pathways, conducting clinical trials, and performing population health analytics. The technology allows for the deployment of structured data collection and automated workflows across various medical environments.
- Apr 2025Series D$17.3M
- Mar 2025Series D$50.7K
- Sep 2024Series D$18.8M
- Jun 2023Series D$82M
#10
Acquired · London, England · founded 2016 · 53 employees$18.1Mraised▾
Leading expert network for healthcare and life sciences. Platform connecting healthcare and life science organizations with subject matter experts. It facilitates primary research by providing access to a network of professionals. The platform offers tools for expert identification, interview scheduling, and automated call analysis. It also provides features for data capture, transcript access, and quote sharing.
- Feb 2026PE$6.7M
- Oct 2021Series B$12M
- Feb 2020Unattributed$4.9M
- Dec 2018Unattributed$1.3M
#11
Series A · London, England · founded 2017 · 19 employees$15Mraised▾
Developer of VR-based medical training systems for patient care. It uses virtual reality headsets and offers a computer-generated, virtual emergency department with an interactive platform for the patient and a nurse. It allows a user to manage the patient as in real life, perform investigations, instigate treatment, and interact with their team. It also provides personalized feedback on their performance including their strengths, team management, patient interaction, and points for improvement.
- Mar 2026Series A$6.6M
- Jan 2024Series A$12.6M
- Oct 2022Series A$2.4M
- Oct 2018Seed—
#12
Series A · London, England · founded 2021$17Mraised▾
Provider of a platform offering clinically governed mental health support. The platform delivers structured journeys, governed content, and intelligent discovery tools. It offers resources for employers, health insurers, healthcare organizations, and commercial partners. The platform provides educational content, AI support, and pathways to appropriate resources.
- Mar 2026Series A$17M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time flat
Funding & growth over time
funding rising · growth rising
How research on Digital Health is moving in the United Kingdom
A read on the academic research around Digital Health — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 4,011 United Kingdom-affiliated papers.
- Imperial College London284
- University College London257
- King's College London242
- London School of Hygiene & Tropical Medicine242
- University of Oxford193
- Health care3→83
- Wearable computer1→41
- Health informatics10→41
- Mental health2→27
- Psychological intervention3→17
- Health care20→268
- Psychological intervention14→207
- Health informatics45→164
- Intervention (counseling)9→123
- Public health15→113
- Health care61→604
- Psychological intervention33→266
- Public health55→286
- Health informatics123→337
- Nursing research60→218
Where digital health is researched across United Kingdom
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing medical devices patents in the United Kingdom
United Kingdom medical devices patent filing is accelerating — 44,661 filings from 8,000 assignees (2016–2025), led by Smith & Nephew, Nicoventures Trading, CREO Medical; annual filings 4010→4019.
- Smith & Nephew3027
- Nicoventures Trading1947
- CREO Medical1678
- OWEN Mumford1481
- CMR Surgical1193
- Gyrus Medical1019
- Sanofi Aventis Deutschland1012
- Convatec868